Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery
Your search for apixaban returned 7 results
Apixaban and rivaroxaban are both factor Xa inhibitors.
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban
No substantial differences seen for other outcomes or for other direct oral anticoagulant comparisons
Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.
FDA Panel votes on the potential removal from the market of Makena; results from an apixaban trial of patients with atrial fibrillation and valvular heart disease; reports of serious ocular complications with monkeypox infection; the novavax vaccine becomes the latest authorized COVID-19 booster; and treatments for nephropathy and ALS have their review period extended.